Compounds > 1,25-dihydroxyergocalciferol
Page last updated: 2024-09-03

1,25-dihydroxyergocalciferol and Bone Diseases, Metabolic

1,25-dihydroxyergocalciferol has been researched along with Bone Diseases, Metabolic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bowman, AR; Bryer, HP; Dissanayake, IR; Epstein, S; Goodman, GR; Jee, WS; Ma, Y; Pun, S1

Other Studies

1 other study(ies) available for 1,25-dihydroxyergocalciferol and Bone Diseases, Metabolic

ArticleYear
Transforming growth factor-beta administration modifies cyclosporine A-induced bone loss.
    Bone, 2001, Volume: 28, Issue:6

    Topics: Animals; Bone Diseases, Metabolic; Bone Resorption; Cyclosporine; Ergocalciferols; Male; Osteocalcin; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta

2001